ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05310	Asthma	2/6	17/7206	7.81482199661e-05
ko05321	Inflammatory bowel disease (IBD)	2/6	56/7206	0.000872203383915
ko04640	Hematopoietic cell lineage	2/6	64/7206	0.00113840549273
ko04658	Th1 and Th2 cell differentiation	2/6	96/7206	0.00254450322645
ko04659	Th17 cell differentiation	2/6	106/7206	0.00309375771265
ko04611	Platelet activation	2/6	163/7206	0.00718553403265
ko05152	Tuberculosis	2/6	187/7206	0.00938023546445
ko05332	Graft-versus-host disease	1/6	18/7206	0.0148993652497
ko05330	Allograft rejection	1/6	24/7206	0.0198245166766
ko05166	HTLV-I infection	2/6	292/7206	0.0220304097941
ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	1/6	28/7206	0.0230965372142
ko05320	Autoimmune thyroid disease	1/6	29/7206	0.0239131185429
ko05340	Primary immunodeficiency	1/6	30/7206	0.024729130984
ko04940	Type I diabetes mellitus	1/6	32/7206	0.026359450471
ko05150	Staphylococcus aureus infection	1/6	36/7206	0.0296132767377
ko04672	Intestinal immune network for IgA production	1/6	37/7206	0.0304253158369
ko05416	Viral myocarditis	1/6	55/7206	0.0449454787331